Biocorrx Inc: Shareholders Board Members Managers and Company Profile | US09073C1062

Business description: Biocorrx Inc

BioCorRx Inc. is an addiction treatment solutions company. The Company is engaged in offering treatment for substance use and other related disorders. Its Beat Addiction Recovery is a substance use disorder recovery program that typically includes its Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app, along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx Weight Loss Program is also a medication-assisted weight-loss program that includes access to concierge on-demand wellness specialists, nutritionists, fitness experts, and personal support from behavioral experts. It also controls BioCorRx Pharmaceuticals Inc., a clinical-stage drug development subsidiary, which is seeking FDA approval for BICX104, an implantable naltrexone pellet for the treatment of alcohol and opioid use disorders. It is also engaged in the establishment of alcoholism and opioid addiction rehabilitation and treatment centers.

Sales by Activity: Biocorrx Inc

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Alcohol Addiction Treatment	48.27K	214K	89.16K	7.66K	797K

See all business segments

Geographical breakdown of sales: Biocorrx Inc

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
United States	48.27K	214K	89.16K	7.66K	797K

See all geographic segments

Executive Committee: Biocorrx Inc

Manager	Title	Age	Since
Lourdes Felix CEO	Chief Executive Officer	58	2020-11-08
Louis Lucido PSD	President	77	2024-01-04

See BIOCORRX INC governance

Composition of the Board of Directors: Biocorrx Inc

Director	Title	Age	Since
Lourdes Felix BRD	Director/Board Member	58	2013-03-06
Kent Emry CHM	Chairman	57	-
Louis Lucido BRD	Director/Board Member	77	2019-02-28
Luisa Ingargiola BRD	Director/Board Member	58	2018-03-31
Joe Galligan BRD	Director/Board Member	66	2021-02-15
Katherine Beebe-DeVarney BRD	Director/Board Member	65	2024-02-07

Composition of the Board of Directors

Shareholders: Biocorrx Inc

Name	Stocks	%	Valuation
Louis Lucido 18.96 %	5,508,229	18.96 %	2 M $
BICX Holding Co. LLC 7.667 %	2,227,575	7.667 %	757 376 $
Joe Galligan 4.781 %	1,389,212	4.781 %	472 332 $
Lourdes Felix 2.903 %	843,599	2.903 %	286 824 $
Kent Emry 0.5407 %	157,112	0.5407 %	53 418 $

Name	Stocks	%	Valuation
Lourdes Felix 25 %	40,000	25 %	13 600 $
Brady Granier 25 %	40,000	25 %	13 600 $
Kent Emry 25 %	40,000	25 %	13 600 $

Name	Stocks	%	Valuation
Lourdes Felix 12.5 %	10,000	12.5 %	3 400 $
Brady Granier 12.5 %	10,000	12.5 %	3 400 $
Kent Emry 12.5 %	10,000	12.5 %	3 400 $

List of BIOCORRX INC shareholders

Company details: Biocorrx Inc

BioCorRx, Inc.

2390 East Orangewood Avenue

92806, Anaheim

+714 462 4880

http://www.biocorrx.com

Other Healthcare Facilities & Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CVS HEALTH CORPORATION	+0.90%	-2.20%	+68.67%	+37.90%	133B
HCA HEALTHCARE, INC.	+1.00%	+6.39%	+13.91%	+50.94%	87.16B
FRESENIUS SE & CO. KGAA	+0.56%	+2.21%	+8.96%	+56.70%	28.85B
QUEST DIAGNOSTICS INCORPORATED	-0.45%	+1.79%	+35.76%	+72.12%	25.72B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.49%	+6.97%	-9.23%	-16.55%	21.85B
TENET HEALTHCARE CORPORATION	-1.88%	+7.20%	+58.13%	+237.37%	20.51B
DAVITA INC.	-2.67%	-0.75%	+68.75%	+129.17%	15.41B
REDE D'OR SÃO LUIZ S.A.	-1.67%	+1.37%	+2.59%	-1.39%	14.98B
FRESENIUS MEDICAL CARE AG	+0.92%	+3.67%	+3.65%	-3.19%	13.55B
Average	-0.20%	+3.25%	+27.91%	+62.56%	40.14B
Weighted average by Cap.	+0.42%	+1.64%	+37.86%	+53.74%